Postprandial Effects of Bean and Whole Grain Consumption on Arterial Stiffness
A Pilot Study to Examine the Effect of Consuming Beans and Whole Grains at Breakfast on Postprandial Vascular Responses in People With Arterial Stiffness
1 other identifier
interventional
11
1 country
1
Brief Summary
This is a single site, single-blinded, controlled randomized crossover clinical trial designed to compare the effects of black beans or whole grains or white rice at breakfast on postprandial vascular responses in males and females with arterial stiffness (n=10). Eligible participants will be asked to attend 3 in-person visits for comparative testing of black beans versus whole grains versus white rice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2023
CompletedStudy Start
First participant enrolled
April 1, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedFebruary 28, 2025
February 1, 2025
12 months
March 16, 2023
February 25, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change from baseline Augmentation index at 2 hours
Pulse wave analysis using a SphygmoCor XCEL device will be used to measure the augmentation index (AIx), an indicator of arterial stiffness, prior to consumption of the test products, and at 2 hours post-consumption.
Time points 0 (prior to consumption) and 2 hours post consumption.
Change from baseline Reflection magnitude at 2 hours
Pulse wave analysis using a SphygmoCor XCEL device will be used to measure the reflection magnitude, an indicator of arterial stiffness, prior to consumption of the test products, and at 2 hours post-consumption.
Time points 0 (prior to consumption) and 2 hours post consumption.
Secondary Outcomes (1)
Change from baseline blood pressure at 2 hours
Time points 0 (prior to consumption) and 2 hours post consumption.
Study Arms (3)
Black Beans (cooked)
ACTIVE COMPARATORAt one of the three visits, participants will consume a ¾ cup of cooked black beans. Participants will be provided with 100 ml of water with the food, and will be allowed to drink up to another 150 mL of water during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.
Whole Wheat Grain (cooked)
ACTIVE COMPARATORAt one of the three visits, participants will consume a ¾ cup of cooked whole wheat grain. Participants will be provided with 100 ml of water with the food, and will be allowed to drink up to another 150 mL of water during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.
White Rice (cooked)
PLACEBO COMPARATORAt one of the three visits, participants will consume a ¾ cup of cooked white rice. Participants will be provided with 100 ml of water with the food, and will be allowed to drink up to another 150 mL of water during the 2 hour test period. The participants will not be blinded to the order and the type of food product they receive at a visit, however, the samples will be assigned a number to ensure the analytical team is blinded to the test product until the end of the study. Should the need to re-administer a test product arise, the participant will receive the test product from the same treatment number again at an extra visit after the original 3 visits have been completed.
Interventions
Eligibility Criteria
You may qualify if:
- Male, or non-pregnant, non-lactating female, 45 to 65 years of age;
- Brachial-ankle pulse wave velocity \>1400 cm/s on at least one side;
- Plasma creatinine ≤265 µmol/L;
- Aspartate aminotransferase \<160 U/L, andalanine aminotransferase \<150 U/L;
- Glycated hemoglobin ≤6.5%;
- LDL-cholesterol \<5 mmol/L;
- Stable regime if taking vitamin and mineral/dietary/herbal supplements for the past 1 month and while participating in the study;
- Has not donated blood or blood products (e.g. platelets) during the past 2 months and willing to continue doing so while participating in the study;
- Not participating in another dietary intervention trial for the past month and willing to not start another dietary intervention trial for the duration of this study;
- Willing to comply with the protocol requirements and procedures;
- Willing to provide informed consent.
You may not qualify if:
- Has experienced a cardiovascular event (e.g. heart attack, stroke) or had a surgical procedure for cardiovascular disease (e.g. bypass, stent), presence of clinically diagnosed cardiac arrhythmia or valve stenosis, chronic renal disease, liver disease (with exception of fatty liver), lung disease, rheumatoid arthritis, immune disorder or disease (e.g. multiple sclerosis, leukemia), cancer in the previous 5 years, neurological disorders, or gastrointestinal disorders;
- Taking vasoactive medications (e.g., ACE inhibitors, ARBs, AGE-breakers, thiazolidinediones, beta-blockers, statins, insulin, etc.);
- Blood pressure \>160 mmHg systolic and/or \>100 mmHg diastolic;
- History of gastrointestinal reactions or allergies to beans, bean flour, wheat, wheat flour, gluten, or rice;
- Body weight exceeds the capacity of the DEXA (350 lbs);
- Current (within the past 30 days) bacterial, viral or fungal infection;
- Bleeding disorder;
- Amputations of upper or lower extremities on both sides;
- Any acute medical condition or surgical intervention within the past 3 months;
- Drug and/or alcohol abuse;
- Psychological disorder(s);
- Unable to fast overnight;
- Unable to take prescribed medication without food;
- Unable to obtain vascular function measurements and/or blood sample at the screening or first study visits;
- Not fully vaccinated for COVID-19.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asper Clinical Research Institute
Winnipeg, Manitoba, R3E 0T5, Canada
Related Publications (1)
Zahradka P, Perera D, Charney J, Taylor CG. Distinct Effects of Wheat and Black Bean Consumption on Postprandial Vascular Responses in People with Arterial Stiffness: A Pilot Randomized Cross-Over Study. Nutrients. 2025 Mar 27;17(7):1159. doi: 10.3390/nu17071159.
PMID: 40218917DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
March 16, 2023
First Posted
April 18, 2023
Study Start
April 1, 2023
Primary Completion
March 22, 2024
Study Completion
April 30, 2024
Last Updated
February 28, 2025
Record last verified: 2025-02